Voyager Therapeutics, Inc. Common Stock Share Price
NASDAQ: VYGRHealthcare
Live Voyager Therapeutics, Inc. Common Stock Share Price Chart
O H L
Voyager Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$2.37Low
$2.51High
Markets Today
| Previous Close | $2.37 |
|---|---|
| Open | $2.39 |
| Volume | 686,342 |
| Day's Range | $2.37 - $2.51 |
| 52W Range | $2.33 - $5.55 |
| Market Cap | $146.03 M |
Historical Performance
| 1M Returns | -23.20 |
|---|---|
| 3M Returns | -28.78 |
| 6M Returns | -34.49 |
| 1Y Returns | -51.00 |
| 5Y Returns | -48.96 |
| 10Y Returns | -79.72 |
Voyager Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $146.03 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $40.37 M |
| ROE TTM | -0.48 |
| EPS TTM | $-1.81 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.94 |
| EBITDA | $-127.78 M |
| Profit Margin | -296.53 |
| Market Cap | $146.03 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $40.37 M |
| ROE TTM | -0.48 |
| EPS TTM | $-1.81 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.94 |
| EBITDA | $-127.78 M |
| Profit Margin | -296.53 |
Voyager Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $6.47 M | $5.20 M | $13.37 M | $15.34 M | $2.59 M | $3.17 M |
| Gross Profit + | $6.47 M | $5.20 M | $13.37 M | $15.34 M | $2.59 M | $3.17 M |
| Operating Income | -$34.69 M | -$36.63 M | -$30.59 M | -$29.93 M | -$30.27 M | -$26.39 M |
| EBITDA | -$33.68 M | -$35.56 M | -$29.66 M | -$28.88 M | -$29.34 M | -$25.48 M |
| Interest Expense | $0 | $2.83 M | $0 | $0 | $0 | $1.53 M |
| Depreciation | $1.01 M | $1.06 M | $932.00 K | $1.05 M | $932.00 K | $908.00 K |
| Income Before Tax | -$30.98 M | -$33.37 M | -$27.81 M | -$27.42 M | -$27.92 M | -$24.45 M |
| Income Tax Expense | $37.00 K | $15.00 K | $83.00 K | $9.00 K | $14.00 K | $20.00 K |
| Net Income + | -$31.02 M | -$33.38 M | -$27.89 M | -$27.43 M | -$27.94 M | -$24.47 M |
| Net Profit Margin | -479.24% | -641.96% | -208.69% | -178.83% | -1077.4% | -773.24% |
Voyager Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $55.00 K | $56.00 K | $56.00 K | $59.00 K | $60.00 K | $61.00 K |
| Reserve & Surplus | -$357.40 M | -$390.81 M | -$418.47 M | -$445.87 M | -$474.11 M | -$498.74 M |
| Non-Current Liabilities | $40.33 M | $36.17 M | $32.99 M | $29.66 M | $28.20 M | $26.69 M |
| Current Liabilities | $40.21 M | $41.98 M | $35.49 M | $26.54 M | $17.45 M | $16.68 M |
| Total Liabilities | $80.54 M | $78.16 M | $68.49 M | $56.20 M | $45.66 M | $43.38 M |
| Fixed Assets | $13.93 M | $13.92 M | $13.29 M | $13.14 M | $12.22 M | $11.19 M |
| Current Assets | $245.21 M | $227.89 M | $219.59 M | $202.69 M | $146.98 M | $125.23 M |
| Total Assets | $353.24 M | $322.10 M | $288.31 M | $252.28 M | $219.32 M | $197.75 M |
Voyager Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$31.02 M | -$33.38 M | -$27.89 M | -$27.43 M | -$27.94 M | -$24.47 M |
| Operating Cash Flow | -$37.90 M | -$33.26 M | -$31.05 M | -$30.26 M | -$33.42 M | -$25.84 M |
| Investing Cash Flow | $41.20 M | $1.93 M | $34.89 M | $47.42 M | $8.10 M | $15.39 M |
| Financing Cash Flow | $82.00 K | $513.00 K | $85.00 K | $136.00 K | $3.33 M | $2.91 M |
| Change in Cash | $3.39 M | -$30.82 M | $3.92 M | $17.30 M | -$21.99 M | -$7.54 M |
Voyager Therapeutics, Inc. Common Stock Return Calculator
The Voyager Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$4,288
Invested Amount$10,000
Est. Returns$-5,712
About Voyager Therapeutics, Inc. Common Stock
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
Popular Stocks
FAQs
What is the share price of Voyager Therapeutics, Inc. Common Stock today?
Voyager Therapeutics, Inc. Common Stock (VYGR) share price as of October 10, 2026 is $2.38. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Voyager Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Voyager Therapeutics, Inc. Common Stock (VYGR) Share by opening an international trading account with Angel One.
How can I purchase Voyager Therapeutics, Inc. Common Stock shares in India?
Purchasing Voyager Therapeutics, Inc. Common Stock (VYGR) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Voyager Therapeutics, Inc. Common Stock (VYGR) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Voyager Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Voyager Therapeutics, Inc. Common Stock (VYGR) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Voyager Therapeutics, Inc. Common Stock?
The market capitalization of Voyager Therapeutics, Inc. Common Stock on October 10, 2026, is $146.03 M.
In which sector Voyager Therapeutics, Inc. Common Stock belongs?
Voyager Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Voyager Therapeutics, Inc. Common Stock stocks?
In order to invest in Voyager Therapeutics, Inc. Common Stock (VYGR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
